Tolvaptan
Brand name: Jynarque
Rank #320 of 500 drugs by total cost
$34.4M
Total Cost
2,760
Total Claims
$34.4M
Total Cost
174
Prescribers
$12K
Cost per Claim
0
Beneficiaries
2,891
30-Day Fills
$197K
Avg Cost/Provider
16
Avg Claims/Provider
About Tolvaptan
Tolvaptan (sold as Jynarque) was prescribed 2,760 times by 174 Medicare Part D providers in 2023, costing the program $34.4M. At $12K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 317 | Trametinib Dimethyl Sulfoxide (Mekinist) | $35.0M | 2,448 |
| 318 | Isosorbide Mononitrate (Isosorbide Mononitrate Er) | $34.5M | 1,805,114 |
| 319 | Clonazepam (Clonazepam) | $34.4M | 3,685,968 |
| 320 | Tolvaptan (Jynarque) | $34.4M | 2,760 |
| 321 | Dalfampridine (Dalfampridine Er) | $34.1M | 40,425 |
| 322 | Olmesartan Medoxomil (Olmesartan Medoxomil) | $33.8M | 1,102,412 |
| 323 | Niraparib Tosylate (Zejula) | $33.7M | 2,206 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology